$RichWire Markets and money, explained simply

LIVE

02:59 Garmin Valuation Concerns: Fundamentals Outpace Stock Price Above $200 02:44 Nvidia Alters Singapore Revenue Reporting Amid Megaspeed Scrutiny and Leadership Shakeup 02:38 Legacy Education Reports First Quarter Fiscal 2027 Results 02:36 American Electric Power Unveils $100 Billion Five-Year Plan to Meet Surging Electricity Demand 02:19 Freelancer Details Platform Scale and Revenue Breakdown at Investor Event 02:09 Pelthos Therapeutics Reports 114% Surge in Third-Quarter Revenue 02:08 Fincantieri Posts Q3 EBITDA Jump Despite Flat Revenue 02:00 Prediction Markets Point to Potential Successors as Nvidia Faces Leadership Transition 01:59 M-tron Industries Hosts Third-Quarter 2026 Earnings Call 01:59 Belite Bio Outlines Progress During Third Quarter 2026 Earnings Call 01:39 BioCardia Details Financial Results and Corporate Strategy in Third-Quarter 2026 Update 01:39 INVE Technologies Holds Q3 2026 Earnings Call Under New Identity 02:59 Garmin Valuation Concerns: Fundamentals Outpace Stock Price Above $200 02:44 Nvidia Alters Singapore Revenue Reporting Amid Megaspeed Scrutiny and Leadership Shakeup 02:38 Legacy Education Reports First Quarter Fiscal 2027 Results 02:36 American Electric Power Unveils $100 Billion Five-Year Plan to Meet Surging Electricity Demand 02:19 Freelancer Details Platform Scale and Revenue Breakdown at Investor Event 02:09 Pelthos Therapeutics Reports 114% Surge in Third-Quarter Revenue 02:08 Fincantieri Posts Q3 EBITDA Jump Despite Flat Revenue 02:00 Prediction Markets Point to Potential Successors as Nvidia Faces Leadership Transition 01:59 M-tron Industries Hosts Third-Quarter 2026 Earnings Call 01:59 Belite Bio Outlines Progress During Third Quarter 2026 Earnings Call 01:39 BioCardia Details Financial Results and Corporate Strategy in Third-Quarter 2026 Update 01:39 INVE Technologies Holds Q3 2026 Earnings Call Under New Identity

Topic: Clinical Trials

Olema Pharmaceuticals Updates Investors on Clinical Trials at Healthcare Conference

Companies1 h ago

Olema Pharmaceuticals Updates Investors on Clinical Trials at Healthcare Conference

Olema Pharmaceuticals CEO discussed the company's upcoming Phase III data readouts and clinical trial momentum at a recent healthcare conference.

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.